Healthcare Stock Comparison

Compare the best healthcare stocks, get the most updated comparison by key indicators and discover each stock’s price target as well as recommendations by top Wall Street experts.
Compare up to 7 stocks

Comparison Results

Name
Price
Price Change
Price Target Upside
Market Cap
PE Ratio
Yearly Gain
Analyst Consensus
Follow
PFEPfizer
$40.05
-0.06 (-0.15%)
$43.10
(7.62% Upside)
224.19B
20.30
15.56%
1Buy
10Hold
0Sell
0
Hold
NVSNovartis
$88.70
0.15 (0.17%)
$104.08
(17.34% Upside)
199.14B
25.50
7.54%
3Buy
1Hold
1Sell
0
Moderate Buy
MRKMerck & Company
$79.38
-0.49 (-0.61%)
$89.43
(12.66% Upside)
200.99B
28.40
1.37%
5Buy
2Hold
0Sell
0
Moderate Buy
JNJJohnson & Johnson
$170.45
0.06 (0.04%)
$190.40
(11.70% Upside)
448.86B
30.10
16.14%
4Buy
1Hold
0Sell
0
Strong Buy
RHHBYRoche Holding
$42.72
0.52 (1.23%)
291.56B
18.10
-4.76%
0Buy
1Hold
0Sell
0
Hold

Performance Comparison

Compare the performance , dividend, and cannabis stocks. Go to the Stock Comparison tool to compare more stocks on key indicators.

Healthcare Stocks Latest News

Read the latest stock news and analysis from the TipRanks news team.

Recent Analysts Ratings of Healthcare Stocks

Name
Analyst
Analyst Firm
Rating
Price Target
Upside / Downside
Action
Date
MRKMerck & Company
Buy
Reiterated
PFEPfizer Inc
Hold
Reiterated
NVSNovartis AG
Sell
Reiterated
JNJJohnson & Johnson
Buy
Assigned
RHHBYRoche Holding AG
Hold
Downgraded
PFEPfizer Inc
Hold
Downgraded
PFEPfizer Inc
Hold
Reiterated
PFEPfizer Inc
Hold
Reiterated
MRKMerck & Company
Buy
Reiterated
PFEPfizer Inc
Hold
Reiterated

Most Recent Earnings of Healthcare Stocks

SYMBOL
Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
PFEPfizer
May 04, 2021
2021 (Q1)
0.78/0.86
0.606
42.08% (+0.26)
NVSNovartis
Apr 27, 2021
2021 (Q1)
1.54/
0.958
MRKMerck & Company
Apr 29, 2021
2021 (Q1)
1.61/1.25
1.264
-1.03% (-0.01)
JNJJohnson & Johnson
Apr 20, 2021
2021 (Q1)
2.34/2.32
2.17
6.87% (+0.15)
RHHBYRoche Holding
Feb 04, 2021
2020 (Q4)
1.28/1.00
0.721
38.14% (+0.28)

Healthcare Stocks - FAQ

Which Healthcare stocks have a "Strong Buy" analyst rating?
These Healthcare stocks currently have a "Strong Buy" analyst rating consensus:
Johnson & Johnson - Strong Buy, based on 5 analyst ratings, 4 Buy, 1 Hold, and 0 Sell.
Are Healthcare stocks overpriced?
Pfizer's stock price is currently $40.05, and its average 12-month price target is $43.10.
Novartis's stock price is currently $88.70, and its average 12-month price target is $104.08.
Merck & Company's stock price is currently $79.38, and its average 12-month price target is $89.43.
Johnson & Johnson's stock price is currently $170.45, and its average 12-month price target is $190.40.
Roche Holding's stock price is currently $42.72, and its average 12-month price target is N/A.
Which Healthcare stocks pay dividends?
Pfizer does not currently pay dividends.
Novartis does not currently pay dividends.
Merck & Company does not currently pay dividends.
Johnson & Johnson currently pays a dividend of $1.06 which represents an annual dividend yield of 2.37%. Johnson & Johnson's next Ex-dividend date is May 24, 2021 and its next payout date is June 8, 2021.
Roche Holding does not currently pay dividends.